We are proud to announce our collaboration with Professor Lavigne’s team at the Nîmes University Hospitals to combine our expertise in the design of new anti-UPEC (uropathogenic E. coli) solutions. Our scientific partnership aims to design effective phage cocktails against epidemic and multi-drug resistant clinical strains.

With this collaboration and in a One Health approach, Greenphage participates to tackle the public health problem of uropathogenic E. coli infections and address the significant medical need caused by antimicrobial resistance.